Analysis of patent litigation, PTAB practice, prosecution and pharma IP, written on the data behind LexDana.
Tagged patent rights · clear
In OSI v. Apotex, Appeal no. 2018-1925 (Fed. Cir., October 4, 2019) , the panel reversed the PTAB and found that the method of treatment claims in U.S. Pat. No. 6,900,221 were not obvious over a primary reference taken with each of two secondary…
Under U.S. law, inventors own patent rights to their inventions unless and until they transfer such rights to another. Earlier this month, the Federal Circuit issued a decision in Advanced Video Technologies v. HTC Corp. in which a co-inventor refused to…
Please revisit Don Chisum’s and Janice Mueller’s comments on Impression Products v. Lexmark, No. 151189 (S. Ct. May 30, 2017), in which the Court held that a seller of a patented printer cartridge had exhausted its patent rights, so that a…
